Actinium Pharmaceuticals, Inc. (ATNM) stock
ATNMNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/3085% below fair value
$1.08−0.27 (-20.00%)
Close on Nov 18, 2026Market cap $33.96MP/E 3.0Yield –
Actinium Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Actinium Pharmaceuticals's price to book ratio was 1.6× on Nov 11, 2026, against 3.1× a year earlier. Over the last 5 years it ranged from 0.9× to 17.2×, with a median of 2.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.6× | −1.4 |
| 2025 | Dec 31, 2025 | 3.1× | +2.0 |
| 2024 | Dec 31, 2024 | 1.0× | −2.2 |
| 2023 | Dec 29, 2023 | 3.2× | −0.6 |
| 2022 | Dec 30, 2022 | 3.8× | +2.1 |
| 2021 | Dec 31, 2021 | 1.6× | −0.7 |
| 2020 | Dec 31, 2020 | 2.3× | −1.3 |
| 2019 | Dec 31, 2019 | 3.6× | −0.1 |
| 2018 | Dec 31, 2018 | 3.7× | +0.8 |
| 2017 | Dec 29, 2017 | 2.9× | −0.0 |
| 2016 | Dec 30, 2016 | 2.9× | −3.0 |
| 2015 | Dec 31, 2015 | 5.9× | −67.6 |
| 2014 | Dec 31, 2014 | 73.6× | −157.0 |
| 2013 | Dec 31, 2013 | 230.6× | – |
See a number that looks wrong?